Molymem is a company focused on developing advanced membranes designed to improve the efficiency of separation processes, particularly in water treatment applications such as desalination and industrial contaminant removal. Their technology emphasizes the creation of membranes that offer high water permeance, selective species rejection, and resistance to corrosion. By addressing global water and wastewater challenges, Molymem aims to support industries and municipalities in minimizing their environmental impact and managing water resources more effectively.
Biorelate provides biomedical research services. It engages in the research of biomarkers for the diagnosis of prostate cancer; target validation; and new drug development services. Daniel Jamison founded Biorelate in 2014. It has its headquarters in Oldham in the United Kingdom.
Biorelate provides biomedical research services. It engages in the research of biomarkers for the diagnosis of prostate cancer; target validation; and new drug development services. Daniel Jamison founded Biorelate in 2014. It has its headquarters in Oldham in the United Kingdom.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.